189 related articles for article (PubMed ID: 18756595)
1. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.
Togo N; Ohwada S; Sakurai S; Toya H; Sakamoto I; Yamada T; Nakano T; Muroya K; Takeyoshi I; Nakajima T; Sekiya T; Yamazumi Y; Nakamura T; Akiyama T
World J Gastroenterol; 2008 Aug; 14(31):4880-8. PubMed ID: 18756595
[TBL] [Abstract][Full Text] [Related]
2. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
3. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
5. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancer.
Elzagheid A; Buhmeida A; Korkeila E; Collan Y; Syrjänen K; Pyrhönen S
World J Gastroenterol; 2008 Aug; 14(31):4903-8. PubMed ID: 18756598
[TBL] [Abstract][Full Text] [Related]
7. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
[TBL] [Abstract][Full Text] [Related]
8. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.
Sekiya T; Adachi S; Kohu K; Yamada T; Higuchi O; Furukawa Y; Nakamura Y; Nakamura T; Tashiro K; Kuhara S; Ohwada S; Akiyama T
J Biol Chem; 2004 Feb; 279(8):6840-6. PubMed ID: 14660579
[TBL] [Abstract][Full Text] [Related]
9. Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.
Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Jirström K; Manjer J
BMC Cancer; 2014 May; 14():371. PubMed ID: 24885829
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
11. Expression of BAMBI and its combination with Smad7 correlates with tumor invasion and poor prognosis in gastric cancer.
Zhang Y; Yu Z; Xiao Q; Sun X; Zhu Z; Zhang J; Xu H; Wei M; Sun M
Tumour Biol; 2014 Jul; 35(7):7047-56. PubMed ID: 24752577
[TBL] [Abstract][Full Text] [Related]
12. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
13. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
[TBL] [Abstract][Full Text] [Related]
14. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
15. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
[TBL] [Abstract][Full Text] [Related]
18. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
19. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
20. Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer.
Guo YT; Qiu CZ; Huang ZX; Yu WS; Yang XF; Wang MZ
World J Gastroenterol; 2015 Dec; 21(48):13473-9. PubMed ID: 26730158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
